All In MedTech

Device Trial Radar · NCT04088331

Artificial Urinary Sphincter Clinical Outcomes

Last checked: Nov 20, 2026Latest source record: Jan 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

145

Actual

Start

Oct 14, 2019

Primary completion

May 13, 2024

Study completion May 13, 2024

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Sep 12, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
Male only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To evaluate the AMS 800 Artificial Urinary Sphincter (AUS) in men with primary stress urinary incontinence as measured by pad weight tests.

Conditions

  • Stress Urinary Incontinence

Interventions

  • AMS 800 Artificial Urinary SphincterDevice

    The AMS 800 Artificial Urinary Sphincter (AUS) is an implantable, fluid filled, solid silicone elastomer device used to treat stress urinary incontinence due to reduced urethral/bladder outlet resistance (intrinsic sphincter deficiency). It is designed to restore the natural process of urinary control. The device simulates normal sphincter function by opening and closing the urethra under the control of the patient.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects With Reduction in 24 Hour Pad Weight Test at 12 MonthsTime frame: 12 months

Locations

18 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California, San Francisco

    San Francisco, California

  • University of Colorado Hospital

    Aurora, Colorado

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

15 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.